Carolina Rocha-Tesi

Central Parkway
Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

When Guillain-Barré syndrome is not monophasic: Distinguishing recurrent Guillain-Barré syndrome from acuteonset chronic inflammatory demyelinating polyneuropathy and nodopathies

When Guillain-Barré syndrome is not monophasic: Distinguishing recurrent Guillain-Barré syndrome from acuteonset chronic inflammatory demyelinating polyneuropathy and nodopathies

Journal: Medicina

Published: August 27, 2026

Eteplirsen Treatment for Duchenne Muscular Dystrophy: A Qualitative Patient Experience Study.

Eteplirsen Treatment for Duchenne Muscular Dystrophy: A Qualitative Patient Experience Study.

Journal: Advances in therapy

Published: March 04, 2024

Major Adverse Dystrophinopathy Events (MADE) Score as Marker of Cumulative Morbidity and Risk for Mortality in Boys with Duchenne Muscular Dystrophy.

Major Adverse Dystrophinopathy Events (MADE) Score as Marker of Cumulative Morbidity and Risk for Mortality in Boys with Duchenne Muscular Dystrophy.

Journal: Progress in pediatric cardiology

Published: November 22, 2023

Assessing the Assisted Six-Minute Cycling Test as a Measure of Endurance in Non-Ambulatory Patients with Spinal Muscular Atrophy (SMA).

Assessing the Assisted Six-Minute Cycling Test as a Measure of Endurance in Non-Ambulatory Patients with Spinal Muscular Atrophy (SMA).

Journal: Journal of clinical medicine

Published: September 02, 2023

Cerebrospinal Fluid Proteomic Changes after Nusinersen in Patients with Spinal Muscular Atrophy.

Cerebrospinal Fluid Proteomic Changes after Nusinersen in Patients with Spinal Muscular Atrophy.

Journal: Journal of clinical medicine

Published: September 01, 2023

Correction to: Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study.

Correction to: Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: November 03, 2021

Knee Strength and Ankle Range of Motion Impacts on Timed Function Tests in Duchenne Muscular Dystrophy: In the Era of Glucocorticoids.

Knee Strength and Ankle Range of Motion Impacts on Timed Function Tests in Duchenne Muscular Dystrophy: In the Era of Glucocorticoids.

Journal: Journal of neuromuscular diseases

Published: November 01, 2021

Advances in the Therapy of Spinal Muscular Atrophy.

Advances in the Therapy of Spinal Muscular Atrophy.

Journal: The Journal of pediatrics

Published: February 18, 2021

Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study.

Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: December 30, 2020

Medical management of muscle weakness in Duchenne muscular dystrophy.

Medical management of muscle weakness in Duchenne muscular dystrophy.

Journal: PloS one

Published: July 21, 2020

50 Years Ago in The Journal of Pediatrics: Chronic Polyneuritis of Childhood.

50 Years Ago in The Journal of Pediatrics: Chronic Polyneuritis of Childhood.

Journal: The Journal of pediatrics

Published: April 28, 2019

Assessment of disease progression in dysferlinopathy: A 1-year cohort study.

Assessment of disease progression in dysferlinopathy: A 1-year cohort study.

Journal: Neurology

Published: May 04, 2018

Showing 1-12 of 19

Last Updated: 09/26/2026